Circulating Tumor DNA in Bladder Cancer: Novel Applications and Future Directions
Eur Urol
.
2018 Apr;73(4):541-542.
doi: 10.1016/j.eururo.2017.10.011.
Epub 2017 Oct 31.
Authors
Manuel Caitano Maia
1
,
Petros Grivas
2
,
Neeraj Agarwal
3
,
Sumanta K Pal
4
Affiliations
1
Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
2
Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
3
Division of Medical Oncology, University of Utah Huntsman Cancer Institute, Salt Lake City, UT, USA.
4
Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA. Electronic address: spal@coh.org.
PMID:
29097099
DOI:
10.1016/j.eururo.2017.10.011
No abstract available
Publication types
Editorial
Comment
MeSH terms
Biomarkers, Tumor
Circulating Tumor DNA*
Forecasting
Humans
Neoplastic Cells, Circulating
Urinary Bladder Neoplasms*
Substances
Biomarkers, Tumor
Circulating Tumor DNA